A program that got caught up in HHS' decision to abandon mRNA research was revived by a public-private coalition and is now beginning a large, late-stage test that could support a future approval.
Healthcare Dive published a clinical update in Research Highlights on 22 Apr 2026.
The item focuses on Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial.
Review the original article for the full source wording and details.